Meir Fischer

Title: Meir Fischer: Innovator in Genetic Engineering

Introduction

Meir Fischer is a prominent inventor based in Rehovot, Israel, known for his significant contributions to the field of genetic engineering. With a total of eight patents to his name, Fischer has made remarkable advancements in the development of expression plasmids and their applications in biotechnology.

Latest Patents

Fischer's latest patents include innovative plasmids that utilize the deo promoter and bacterial hosts. These plasmids enable the expression of DNA encoding naturally-occurring polypeptides or their analogs in suitable Escherichia coli hosts. Additionally, he has developed plasmids that thermoinducibly direct the expression of eukaryotic genes under the control of a λ P_L promoter, along with a thermolabile repressor protein. These advancements allow for the production of various polypeptides, including human copper/zinc superoxide dismutase and human growth hormone. Furthermore, Fischer has created expression plasmids regulated by an osmB promoter, which facilitate the expression of polypeptides such as superoxide dismutases and growth hormones.

Career Highlights

Throughout his career, Meir Fischer has worked with notable companies in the biotechnology sector, including Bio-Technology General Corporation and American Cyanamid Company. His work has significantly impacted the field, leading to advancements in genetic engineering and biotechnology applications.

Collaborations

Fischer has collaborated with esteemed colleagues, including Michael R. Lebens and Deborah Tardy Chaleff, contributing to various projects and innovations in the field.

Conclusion

Meir Fischer's contributions to genetic engineering through his patents and collaborations have established him as a key figure in biotechnology. His work continues to influence the development of new technologies and applications in the industry.